These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38145778)
1. Co-encapsulation of fisetin and cisplatin into liposomes: Stability considerations and in vivo efficacy on lung cancer animal model. Renault-Mahieux M; Seguin J; Vieillard V; Le DT; Espeau P; Lai-Kuen R; Richard C; Mignet N; Paul M; Andrieux K Int J Pharm; 2024 Feb; 651():123744. PubMed ID: 38145778 [TBL] [Abstract][Full Text] [Related]
2. Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy. Seguin J; Brullé L; Boyer R; Lu YM; Ramos Romano M; Touil YS; Scherman D; Bessodes M; Mignet N; Chabot GG Int J Pharm; 2013 Feb; 444(1-2):146-54. PubMed ID: 23380621 [TBL] [Abstract][Full Text] [Related]
3. Co-Encapsulation of Fisetin and Cisplatin into Liposomes for Glioma Therapy: From Formulation to Cell Evaluation. Renault-Mahieux M; Vieillard V; Seguin J; Espeau P; Le DT; Lai-Kuen R; Mignet N; Paul M; Andrieux K Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34206986 [TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534 [TBL] [Abstract][Full Text] [Related]
5. A Method for Liposome Co-encapsulation of Phenethyl Isothiocyanate and Cisplatin and Determining Its Toxicity Against Lung and Lung Cancer Cells. Sun M; Di Pasqua AJ Methods Mol Biol; 2021; 2279():241-253. PubMed ID: 33683699 [TBL] [Abstract][Full Text] [Related]
6. Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids. Kieler-Ferguson HM; Chan D; Sockolosky J; Finney L; Maxey E; Vogt S; Szoka FC Eur J Pharm Sci; 2017 May; 103():85-93. PubMed ID: 28263913 [TBL] [Abstract][Full Text] [Related]
7. Development of a liposomal formulation of the natural flavonoid fisetin. Mignet N; Seguin J; Ramos Romano M; Brullé L; Touil YS; Scherman D; Bessodes M; Chabot GG Int J Pharm; 2012 Feb; 423(1):69-76. PubMed ID: 21571054 [TBL] [Abstract][Full Text] [Related]
8. Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice. Touil YS; Seguin J; Scherman D; Chabot GG Cancer Chemother Pharmacol; 2011 Aug; 68(2):445-55. PubMed ID: 21069336 [TBL] [Abstract][Full Text] [Related]
10. Phenethyl Isothiocyanate and Cisplatin Co-Encapsulated in a Liposomal Nanoparticle for Treatment of Non-Small Cell Lung Cancer. Sun M; Shi Y; Dang UJ; Di Pasqua AJ Molecules; 2019 Feb; 24(4):. PubMed ID: 30813352 [TBL] [Abstract][Full Text] [Related]
11. Development of β-elemene and Cisplatin Co-Loaded Liposomes for Effective Lung Cancer Therapy and Evaluation in Patient-Derived Tumor Xenografts. Cao M; Long M; Chen Q; Lu Y; Luo Q; Zhao Y; Lu A; Ge C; Zhu L; Chen Z Pharm Res; 2019 Jun; 36(8):121. PubMed ID: 31214786 [TBL] [Abstract][Full Text] [Related]
12. Anticancer activity of a combination of cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors. Tripathi R; Samadder T; Gupta S; Surolia A; Shaha C Mol Cancer Ther; 2011 Feb; 10(2):255-68. PubMed ID: 21216935 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant. Yu DD; Wang CT; Shi HS; Li ZY; Pan L; Yuan QZ; Leng F; Wen Y; Chen X; Wei YQ J Exp Clin Cancer Res; 2010 May; 29(1):46. PubMed ID: 20462440 [TBL] [Abstract][Full Text] [Related]
14. Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC. Pal K; Madamsetty VS; Dutta SK; Mukhopadhyay D Int J Nanomedicine; 2019; 14():5109-5123. PubMed ID: 31371950 [TBL] [Abstract][Full Text] [Related]
15. Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes. Silva H; Silva AC; Lemos FO; Monte-Neto RL; Fontes AP; Lopes MT; Frézard F Anticancer Drugs; 2013 Feb; 24(2):131-9. PubMed ID: 23011234 [TBL] [Abstract][Full Text] [Related]
16. Caprylate-conjugated Cisplatin for the development of novel liposomal formulation. Vhora I; Khatri N; Desai J; Thakkar HP AAPS PharmSciTech; 2014 Aug; 15(4):845-57. PubMed ID: 24700295 [TBL] [Abstract][Full Text] [Related]
17. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer. Wang F; Chen L; Zhang R; Chen Z; Zhu L J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829 [TBL] [Abstract][Full Text] [Related]
18. Tumor delivery of liposomal doxorubicin prepared with poly-L-glutamic acid as a drug-trapping agent. Miatmoko A; Kawano K; Yoda H; Yonemochi E; Hattori Y J Liposome Res; 2017 Jun; 27(2):99-107. PubMed ID: 26982164 [TBL] [Abstract][Full Text] [Related]
19. Liposomes Co-Encapsulating Cisplatin/Mifepristone Improve the Effect on Cervical Cancer: In Vitro and In Vivo Assessment. Ledezma-Gallegos F; Jurado R; Mir R; Medina LA; Mondragon-Fuentes L; Garcia-Lopez P Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32971785 [TBL] [Abstract][Full Text] [Related]
20. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer. Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]